1] Dialysis Vascular Access Research Group, Division of Nephrology, University of Cincinnati, Cincinnati, Ohio, USA [2] Cincinnati Veterans Affairs Medical Center, Cincinnati, Ohio, USA.
Kidney Int. 2013 Dec;84(6):1076-8. doi: 10.1038/ki.2013.307.
Arteriovenous fistula (AVF) maturation continues to cause significant morbidity and mortality. Despite the magnitude of the clinical problem, however, there are no effective clinical or biological predictors of AVF success or failure. Caroli et al. describe an innovative technology that may be successful in predicting AVF flow and diameter using standard-of-care preoperative inputs. Pending additional longer-term validation, the use of this technology could help us get the right access into the right patient at the right time.
动静脉瘘（AVF）成熟仍然会导致严重的发病率和死亡率。然而，尽管这是一个严重的临床问题，但目前还没有有效的临床或生物学指标来预测 AVF 的成功或失败。Caroli 等人描述了一种创新技术，该技术可能成功地使用标准的术前输入来预测 AVF 的流量和直径。在等待更多的长期验证的同时，这项技术的使用可以帮助我们在正确的时间将正确的通路放入正确的患者体内。
